ResearchHub Text Logo
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify IdentityVerified
CommunitySupportAbout
TermsPrivacyIssuesDocs
Paper
RH Logo
RH LogoRH Logo
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0

LBA68 Efficacy and safety of darolutamide plus androgen-deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) from the phase III ARANOTE trial

Oncology
Internal Medicine
Cancer Research
Show More
Save
TipTip
Document
Download
Flag content
0
TipTip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews

Abstract

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.